Alteogen challenges to KRW 1.8 trillion acromegaly treatment market with Severance Hospital
Alteogen(Soon-Jae Park), a company developing antibody biobetters, announced on the 22nd that the company has signed a co-development agreement of an acromegaly treatment using NexP™-based growth hormone receptors with Severance Hospital Pituitary Gland Tumor Center(Professor Eun-Jik Lee, Cheol-R...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
